ZIM Laboratories gets nod to invest in SIA ZIM Laboratories

05 Aug 2024 Evaluate

ZIM Laboratories has received approval for Investment of upto Euro 1,53,000 in the equity shares of SIA ZIM Laboratories, wholly owned subsidiary of the company. The investment in equity shares of SIA ZIM Laboratories is with an objective of expansion and development of business in the European region.

The company has also received approval for incorporation of a subsidiary of ZIM Laboratories FZE, Sharjah (Wholly owned subsidiary of the Company). Post investment, the newly incorporated subsidiary would be a step-down subsidiary of the Company. The incorporation of step down subsidiary is with an objective of expansion and development of business in the MENA region.  The Board of Directors of the company in their meeting held on August 3, 2024, has approved the same.

ZIM Laboratories manufactures, formulates, and distributes drug delivery systems to develop generic pharmaceutical products.


Zim Laboratories Share Price

109.75 -1.35 (-1.22%)
20-Dec-2024 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1808.50
Dr. Reddys Lab 1342.45
Cipla 1472.45
Lupin 2147.55
Zydus Lifesciences 973.90
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.